Abstract
PC12 pheochromocytoma cells have P2 purinoceptors which are activated by ATP and coupled to Ca2+ influx and catecholamine release. Also PC12 cells have adenosine receptors coupled positively to adenylyl cyclase, and cyclic AMP regulates cell functions such as catecholamine release. The effects of ATP and ATP analogs on cyclic AMP accumulation in PC12 cells were investigated in this study. ATP and adenosine 5'-0-(3-thiotriphosphate) stimulated cyclic AMP accumulation at low concentrations up to 300 microM but showed inhibitory effects above this concentration. 2',3'-O-(4-Benzoyl)benzoyl ATP and 2-methylthio ATP showed similar effects, although the responses were very limited. Addition of adenosine 5'-O-(2-thiodiphosphate) (ADP beta S) or beta, gamma-methylene ATP, but not alpha, beta-methylene ATP, stimulated cyclic AMP accumulation markedly without causing an inhibitory phase. The effects of ATP, ADP beta S and beta, gamma-methylene ATP were not inhibited by adenosine deaminase or specific antagonists to A1 and A2 adenosine receptors. Neither ADp beta S nor beta, gamma-methylene ATP showed any effect on Ca2+ influx or noradrenaline release. Suramin, a P2 receptors antagonists, had no inhibitory effect against ATP analog-stimula...Continue Reading
References
May 7, 1976·Analytical Biochemistry·M M Bradford
Feb 19, 1992·Biochimica Et Biophysica Acta·C el-MoatassimJ C Mani
Sep 9, 1992·Biochimica Et Biophysica Acta·M A MajidY Kondo
Nov 11, 1992·Proceedings of the National Academy of Sciences of the United States of America·P T Martin, D E Koshland
Mar 1, 1991·British Journal of Pharmacology·K InoueA Takanaka
Sep 18, 1992·Cell·W J Tang, A G Gilman
Sep 17, 1990·FEBS Letters·K KurozumiY Nomura
Sep 1, 1990·British Journal of Pharmacology·K NakazawaK Inoue
Mar 1, 1990·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R W Colman
Sep 15, 1989·Biochemical and Biophysical Research Communications·I PianetJ Labouesse
Dec 4, 1989·Neuroscience Letters·K InoueA Takanaka
Oct 24, 1985·Neuroscience Letters·A S TischlerJ Horwitz
Mar 3, 1986·Life Sciences·D UkenaK A Jacobson
Jan 15, 1986·The Biochemical Journal·J L Gordon
Oct 6, 1994·Nature·S ValeraG Buell
Oct 6, 1994·Nature·A J BrakeD Julius
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K D LustigD Julius
Jan 6, 1995·The Journal of Biological Chemistry·R Taussig, A G Gilman
Nov 1, 1993·Journal of Neurochemistry·A R RhoadsP D Wagner
Aug 31, 1993·Biochemical and Biophysical Research Communications·M A MajidY Kondo
Jun 14, 1993·FEBS Letters·T E WebbE A Barnard
Aug 1, 1995·Journal of Biochemistry·H OdaY Nomura
Sep 1, 1995·Japanese Journal of Pharmacology·T MurayamaY Nomura
Citations
Jul 3, 1998·European Journal of Pharmacology·T MurayamaY Nomura
Dec 29, 1998·European Journal of Pharmacology·T NaganumaY Nomura
Jun 18, 1998·British Journal of Pharmacology·D Hillaire-BuysM M Loubatières-Mariani
Mar 22, 2000·British Journal of Pharmacology·S OhkuboI Matsuoka
Feb 9, 2002·British Journal of Pharmacology·Ursula UnterbergerStefan Boehm
Mar 4, 2000·Neuropharmacology·G ArslanB B Fredholm
Aug 6, 2005·Neurochemistry International·Katrin Sak, Peter Illes
Nov 26, 1998·Japanese Journal of Pharmacology·M P Abbracchio, G Burnstock
Oct 5, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·M K ShahP J Kadowitz
Apr 7, 1999·Archives of Biochemistry and Biophysics·T NaganumaY Nomura